CN Patent
CN106620649A — 使用单剂量奥利万星的治疗方法
Assigned to Medicines Co · Expires 2017-05-10 · 9y expired
What this patent protects
糖肽类抗生素例如奥利万星显示针对许多细菌的显著活性。本文描述了在疗程内使用单剂量奥利万星治疗、预防和防止动物(包括人类)的细菌感染和疾病的方法。
USPTO Abstract
糖肽类抗生素例如奥利万星显示针对许多细菌的显著活性。本文描述了在疗程内使用单剂量奥利万星治疗、预防和防止动物(包括人类)的细菌感染和疾病的方法。
Drugs covered by this patent
- Nuzyra (OMADACYCLINE TOSYLATE) · Paratek Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.